Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,812 | 651 | 99.8% |
| Education | $15.64 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,237 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,207 | 78 | $0 (2024) |
| Lilly USA, LLC | $855.56 | 58 | $0 (2024) |
| Novo Nordisk Inc | $757.24 | 42 | $0 (2024) |
| PFIZER INC. | $735.24 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $659.68 | 45 | $0 (2024) |
| ABBVIE INC. | $641.25 | 60 | $0 (2024) |
| Merck Sharp & Dohme LLC | $517.28 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $486.31 | 44 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $361.91 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,753 | 101 | AstraZeneca Pharmaceuticals LP ($459.91) |
| 2023 | $1,700 | 101 | Novo Nordisk Inc ($270.42) |
| 2022 | $1,336 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($222.13) |
| 2021 | $537.01 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($163.35) |
| 2020 | $461.59 | 26 | Boston Scientific Corporation ($116.27) |
| 2019 | $1,581 | 110 | AstraZeneca Pharmaceuticals LP ($282.23) |
| 2018 | $881.36 | 68 | AstraZeneca Pharmaceuticals LP ($152.11) |
| 2017 | $1,578 | 123 | Boehringer Ingelheim Pharmaceuticals, Inc. ($297.54) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 3 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Biological | ||||||
| 05/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Obesity | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: VACCINES | ||||||
| 04/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Diabetes Care | ||||||
| 03/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: DIABETES | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 03/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,070 | 1,418 | $337,515 | $106,957 |
| 2022 | 18 | 1,100 | 1,407 | $315,448 | $97,201 |
| 2021 | 20 | 1,378 | 1,846 | $256,791 | $137,736 |
| 2020 | 22 | 1,307 | 1,839 | $237,081 | $117,487 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 16 | 20 | $1,550 | $965.92 | 62.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 140 | 155 | $3,875 | $597.77 | 15.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $600.00 | $593.40 | 98.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 23 | 23 | $1,564 | $501.40 | 32.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 34 | $2,108 | $336.18 | 15.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 26 | 26 | $234.00 | $112.64 | 48.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 17 | $119.00 | $58.43 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 260 | 520 | $109,324 | $50,306 | 46.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 185 | 382 | $57,458 | $27,972 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 119 | 119 | $23,216 | $17,743 | 76.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 26 | 30 | $14,268 | $7,581 | 53.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 68 | 68 | $10,220 | $5,947 | 58.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 75 | 75 | $5,815 | $4,895 | 84.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 22 | 22 | $4,400 | $4,137 | 94.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 174 | 174 | $4,678 | $3,753 | 80.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 145 | 145 | $4,399 | $3,128 | 71.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 14 | 16 | $4,800 | $2,825 | 58.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 14 | 14 | $3,935 | $2,582 | 65.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 15 | 15 | $2,181 | $1,737 | 79.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 87 | 87 | $3,030 | $1,699 | 56.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 49 | 49 | $2,696 | $1,446 | 53.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 20 | $1,680 | $808.52 | 48.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 33 | 35 | $2,356 | $433.28 | 18.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $515.00 | $292.47 | 56.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 13 | 13 | $661.00 | $266.89 | 40.4% |
About Dr. Christopher Horn, D.O
Dr. Christopher Horn, D.O is a Family Medicine healthcare provider based in Rockaway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821095605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Horn, D.O has received a total of $9,828 in payments from pharmaceutical and medical device companies, with $1,753 received in 2024. These payments were reported across 654 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,812).
As a Medicare-enrolled provider, Horn has provided services to 4,855 Medicare beneficiaries, totaling 6,510 services with total Medicare billing of $459,380. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Rockaway, NJ
- Active Since 07/07/2005
- Last Updated 12/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821095605
Products in Payments
- JARDIANCE (Drug) $1,168
- FARXIGA (Drug) $700.56
- VRAYLAR (Drug) $440.37
- REXULTI (Drug) $361.91
- BREZTRI (Drug) $343.42
- ANORO (Drug) $292.49
- TRELEGY ELLIPTA (Drug) $286.66
- JANUVIA (Drug) $262.17
- PREVNAR 20 (Biological) $246.05
- Wegovy (Drug) $239.58
- TRADJENTA (Drug) $232.13
- Ozempic (Drug) $220.80
- Trintellix (Drug) $202.25
- INVOKANA (Drug) $201.10
- CHANTIX (Drug) $199.72
- UBRELVY (Drug) $177.39
- XARELTO (Drug) $164.43
- TRULICITY (Drug) $156.54
- NURTEC ODT (Drug) $150.66
- STIOLTO RESPIMAT (Drug) $144.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockaway
Christopher Heitzman, D.o, D.O
Family Medicine — Payments: $1,924
Dr. Olympia Sophias, D.o, D.O
Family Medicine — Payments: $467.89
Dr. Aadya Sharma, Md, MD
Family Medicine — Payments: $289.80
Dr. Oluwatoyin Fapohunda-Adekola, Md, MD
Family Medicine — Payments: $190.96
Dr. Ian Brodrick, M.d, M.D
Family Medicine — Payments: $145.14
Christine Sedlacek, Md, MD
Family Medicine — Payments: $104.64